000			02030 a2200457 4500
005			20250514051655.0
264		0	_c20030114
008			200301s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.242612299 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarth, Günter
245	0	0	_aTargeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cNov 2002
300			_a15614-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcyltransferases _xbiosynthesis
650	0	4	_aAlanine Racemase _xdrug effects
650	0	4	_aAntigens, Bacterial _xbiosynthesis
650	0	4	_aBacterial Proteins _xbiosynthesis
650	0	4	_aCarrier Proteins _xbiosynthesis
650	0	4	_aCell Division _xdrug effects
650	0	4	_aDrug Design
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aGene Expression Regulation, Bacterial _xdrug effects
650	0	4	_aGlutamate-Ammonia Ligase _xdrug effects
650	0	4	_aMultienzyme Complexes _xdrug effects
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aOligodeoxyribonucleotides, Antisense _xchemistry
650	0	4	_aRNA, Bacterial _xantagonists & inhibitors
650	0	4	_aRNA, Messenger _xantagonists & inhibitors
650	0	4	_aThionucleotides _xchemistry
650	0	4	_aTime Factors
650	0	4	_aTranscription, Genetic _xdrug effects
650	0	4	_aTuberculosis _xdrug therapy
700	1		_aHorwitz, Marcus A
700	1		_aTabatadze, David
700	1		_aZamecnik, Paul C
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 99 _gno. 24 _gp. 15614-9
856	4	0	_uhttps://doi.org/10.1073/pnas.242612299 _zAvailable from publisher's website
999			_c12235130 _d12235130